108 related articles for article (PubMed ID: 8564244)
1. Absence of a losartan interaction with renal lithium excretion in the rat.
Barthelmebs M; Alt-Tebacher M; Madonna O; Grima M; Imbs JL
Br J Pharmacol; 1995 Oct; 116(4):2166-9. PubMed ID: 8564244
[TBL] [Abstract][Full Text] [Related]
2. Ramipril-induced decrease in renal lithium excretion in the rat.
Barthelmebs M; Grima M; Imbs JL
Br J Pharmacol; 1995 Oct; 116(4):2161-5. PubMed ID: 8564243
[TBL] [Abstract][Full Text] [Related]
3. Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
Burnier M; Pechère-Bertschi A; Nussberger J; Waeber B; Brunner HR
Am J Kidney Dis; 1995 Jul; 26(1):108-15. PubMed ID: 7611241
[TBL] [Abstract][Full Text] [Related]
4. Effects of losartan on renal function in patients with essential hypertension.
Fauvel JP; Velon S; Berra N; Pozet N; Madonna O; Zech P; Laville M
J Cardiovasc Pharmacol; 1996 Aug; 28(2):259-63. PubMed ID: 8856482
[TBL] [Abstract][Full Text] [Related]
5. Effect of sympathetic and angiotensin-aldosterone systems on renal salt conservation in the rat.
Honrath U; Veress AT; Chong CK; Sonnenberg H
Am J Physiol; 1997 Apr; 272(4 Pt 2):F538-44. PubMed ID: 9140056
[TBL] [Abstract][Full Text] [Related]
6. Effects of losartan on the cardiovascular system, renal haemodynamics and function and lung liquid flow in fetal sheep.
Stevenson KM; Gibson KJ; Lumbers ER
Clin Exp Pharmacol Physiol; 1996 Feb; 23(2):125-33. PubMed ID: 8819640
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
8. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner HR
Hypertension; 1993 Sep; 22(3):339-47. PubMed ID: 8349327
[TBL] [Abstract][Full Text] [Related]
9. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats.
Widdop RE; Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 Mar; 108(3):684-8. PubMed ID: 8467356
[TBL] [Abstract][Full Text] [Related]
11. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
12. Midwall left ventricular performance in salt-loaded Dahl rats: effect of AT1 angiotensin II inhibition.
de Simone G; Devereux RB; Camargo MJ; Wallerson DC; Sealey JE; Laragh JH
J Hypertens; 1995 Dec; 13(12 Pt 2):1808-12. PubMed ID: 8903657
[TBL] [Abstract][Full Text] [Related]
13. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
[TBL] [Abstract][Full Text] [Related]
14. Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes.
Edwards RM; Trizna W; Stack EJ; Weinstock J
J Pharmacol Exp Ther; 1996 Jan; 276(1):125-9. PubMed ID: 8558420
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats.
Sacerdote A; Cosenzi A; Bocin E; Molino R; Seculin P; Plazzotta N; Luxich E; Bellini G
J Hypertens; 1995 Dec; 13(12 Pt 2):1670-3. PubMed ID: 8903630
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats.
Crary GS; Swan SK; O'Donnell MP; Kasiske BL; Katz SA; Keane WF
J Am Soc Nephrol; 1995 Oct; 6(4):1295-9. PubMed ID: 8589300
[TBL] [Abstract][Full Text] [Related]
18. Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog.
Chan DP; Sandok EK; Aarhus LL; Heublein DM; Burnett JC
Am J Hypertens; 1992 Jun; 5(6 Pt 1):354-60. PubMed ID: 1524759
[TBL] [Abstract][Full Text] [Related]
19. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
Hatch M; Freel RW; Shahinfar S; Vaziri ND
J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
[TBL] [Abstract][Full Text] [Related]
20. Effect of losartan and enalapril on renal adaptation sodium restriction in rat.
Jover B; Saladini D; Nafrialdi N; Dupont M; Mimran A
Am J Physiol; 1994 Aug; 267(2 Pt 2):F281-8. PubMed ID: 8067389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
